Get the Stockscreener App
1.26
8.62%
0.10
Tilray Brands Inc stock is traded at $1.26, with a volume of 35.64M.
It is up +8.62% in the last 24 hours and down -2.33% over the past month.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
See More
Previous Close:
$1.16
Open:
$1.14
24h Volume:
35.64M
Relative Volume:
1.29
Market Cap:
$1.14B
Revenue:
$788.94M
Net Income/Loss:
$-244.98M
P/E Ratio:
-0.5575
EPS:
-2.26
Net Cash Flow:
$-60.15M
1W Performance:
+5.88%
1M Performance:
-2.33%
6M Performance:
-25.44%
1Y Performance:
-37.16%
1-Day Range:
$1.14
$1.28
1-Week Range:
$1.14
$1.28
52-Week Range:
$1.14
$2.97
Tilray Brands Inc Stock (TLRY) Company Profile
Name
Tilray Brands Inc
Sector
Phone
519.322.8800
Address
655 MADISON AVENUE, NEW YORK
Compare TLRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
1.26 | 1.14B | 788.94M | -244.98M | -60.15M | -0.33 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-05-24 | Reiterated | Alliance Global Partners | Neutral |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-29-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Mar-04-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-18-21 | Initiated | Barclays | Underweight |
| Nov-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-11-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-03-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| May-11-21 | Resumed | Cowen | Outperform |
| May-07-21 | Resumed | Jefferies | Buy |
| May-06-21 | Initiated | Canaccord Genuity | Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-18-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-18-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-01-20 | Reiterated | MKM Partners | Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| May-12-20 | Reiterated | The Benchmark Company | Buy |
| Apr-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Apr-09-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-13-20 | Initiated | BofA/Merrill | Neutral |
| Nov-13-19 | Reiterated | The Benchmark Company | Buy |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-22-19 | Reiterated | Piper Jaffray | Overweight |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Aug-14-19 | Reiterated | The Benchmark Company | Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Neutral |
| Jun-28-19 | Initiated | Consumer Edge Research | Overweight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Initiated | Oppenheimer | Perform |
| May-15-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-13-19 | Initiated | Alliance Global Partners | Neutral |
View All
Tilray Brands Inc Stock (TLRY) Latest News
Tilray stock touches 52-week low at $1.15 amid market challenges - Investing.com Australia
Tilray Brands Inc. stock rises Friday, outperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Stock Price Up 3.9%Here's What Happened - MarketBeat
Tilray increases authorized shares after stockholder vote By Investing.com - Investing.com Australia
Tilray (NASDAQ:TLRY) Hits New 12-Month LowTime to Sell? - MarketBeat
Tilray increases authorized shares after stockholder vote - Investing.com
Exploring December 2024's US Undervalued Small Caps With Insider Buying - Simply Wall St
Cannabis Cultivation Market Set to Witness Significant Growth by 2024-2031: Aphria, Inc., Aurora Cannabis, - EIN News
Tilray Brands, Inc. (TLRY) Flat As Market Sinks: What You Should Know - Yahoo Finance
Tilray Brands Inc. stock remains steady Thursday, still outperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Shares Up 2.6%Time to Buy? - MarketBeat
Atb Cap Markets Brokers Boost Earnings Estimates for Tilray - MarketBeat
Better Marijuana Stock: Aurora Cannabis or Tilray Brands? - MSN
SweetWater Brewing Announces 28th Anniversary Bash With STS9 Headlining an Immersive Jamtronica Experience - Marketscreener.com
Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025 - The Manila Times
Tilray Brands Sets Date for Q2 2025 Earnings Release: Key Financial Results Coming January 9 - StockTitan
Tilray Brands Inc. stock falls Wednesday, underperforms market - MarketWatch
Redecan Cannabis Launches New Limited-Edition Genetics and - GlobeNewswire
Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-roll Line for the Holidays - Yahoo Finance
Tilray Brands Inc. stock rises Tuesday, outperforms market - MarketWatch
Tilray Brands Inc. stock rises Monday, still underperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Stock Price Up 2.9%What's Next? - MarketBeat
Tilray Brands stock price has crashed: time to buy the dip? - MSN
Is Tilray Brands (TLRY) Among the Best Cannabis Stocks To Invest In? - Insider Monkey
Tilray Brands May Bounce (NASDAQ:TLRY) - Seeking Alpha
Tilray Brands, Inc. Appoints Steven M. Cohen as Class III Board Member - Marketscreener.com
Tilray Brands Inc. stock falls Friday, underperforms market - MarketWatch
Tilray appoints new independent board member - Investing.com
Tilray Brands Introduces Herb & Bloom Non-Alcoholic Beverage - MSN
Tilray (NASDAQ:TLRY) Stock Price Down 4%Here's Why - MarketBeat
Here's Why Shareholders May Want To Be Cautious With Increasing Tilray Brands, Inc.'s (NASDAQ:TLRY) CEO Pay Packet - Simply Wall St
Cocktail-Inspired Cannabis Refreshments - Trend Hunter
Tilray Brands Inc. stock falls Thursday, underperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Stock Price Down 1.1%Here's What Happened - MarketBeat
Tilray stock touches 52-week low at $1.22 amid market challenges - Investing.com
Tidal Investments LLC Sells 1,306,242 Shares of Tilray Inc (NASDAQ:TLRY) - MarketBeat
Tilray Inc (TLRY-T) QuotePress Release - The Globe and Mail
Unwrap the Ultimate Holiday Experience with Good Supply’s Flavour-Packed Innovations - The Bakersfield Californian
Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC Beverages - Marketscreener.com
Tilray Brands, Inc. (TLRY) Stock Dips While Market Gains: Key Facts - MSN
Investors Buy Large Volume of Tilray Call Options (NASDAQ:TLRY) - MarketBeat
The Daily Hit: December 11, 2024 - Green Market Report
Tilray (NASDAQ:TLRY) Stock Price Down 4.3%Should You Sell? - MarketBeat
Tilray Canada Launches THC Beverage Holiday Campaign Featuring XMG and Mollo Brands for Festive Season Celebrations - StreetInsider.com
Tilray AMA: Cannabis beverages offer the biggest opportunity - Green Market Report
Tilray (NASDAQ:TLRY) Reaches New 52-Week LowHere's Why - MarketBeat
Tilray Canada Launches THC Beverage Holiday Campaign - GlobeNewswire
Point72 Asset Management L.P. Acquires New Shares in Tilray Inc (NASDAQ:TLRY) - MarketBeat
Tilray Brands Inc. stock falls Tuesday, underperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Stock Price Down 3.2%What's Next? - MarketBeat
Why Tilray Brands (TLRY) Is the Best Beer Stock to Buy Now? - MSN
Tilray Brands Inc Stock (TLRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tilray Brands Inc Stock (TLRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Persofsky Renah | Director |
Nov 08 '24 |
Option Exercise |
1.50 |
11,958 |
17,937 |
75,348 |
| SIMON IRWIN D | President and CEO |
Jul 31 '24 |
Option Exercise |
2.03 |
706,214 |
1,433,614 |
3,637,021 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
703,412 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
468,218 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
583,643 |
| SIMON IRWIN D | President and CEO |
Jul 26 '24 |
Option Exercise |
1.83 |
98,194 |
179,695 |
2,985,109 |
| Merton Carl A | Chief Financial Officer |
Jul 26 '24 |
Option Exercise |
1.83 |
12,166 |
22,264 |
615,102 |
| Looney Thomas P. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
230,038 |
| Hopkinson David G. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
211,185 |
| Herhalt Johann Michael | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
180,514 |
1.61%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):